Protein A of Staphylococcus aureus evokes Th1 type response in mice

被引:24
|
作者
Sinha, P
Ghosh, AK
Das, T
Sa, G
Ray, PK
机构
[1] Bose Inst, Immunotechnol Sect, Calcutta 700054, W Bengal, India
[2] Bose Inst, Anim Physiol Sect, Calcutta 700054, W Bengal, India
关键词
cytokines; immunomodulation; protein A; S-aureus; Th1/Th2; pathway;
D O I
10.1016/S0165-2478(98)00187-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Protein A (PA) of Staphylococcus aureus is known to elicit several cytokines such as IFN gamma, TNF alpha and IL1. However, it has not been delineated yet as to which differentiation pathway lymphocytes follow after stimulation by PA. In this report, we attempted to collect such evidences. Cytokines, such as IFN gamma, IL2, IL4, IL6, IL10, TNF alpha. IL1 alpha and IL1 beta were measured in serum by ELISA. Our results show that 1 mu g dose of PA stimulates the production of IFN gamma (115 +/- 5 pg/ml), TNF alpha (250 +/- 8 pg/ml) and IL1 alpha (100 +/- 5 pg/ml) as compared to control levels of, 22 +/- 2, 20 +/- 2 and 35 +/- 3 pg/ml respectively whereas IL2 and IL1 beta secretion were less (beyond the lower detection limit of the kit and 25 +/- 1 pg/ml, respectively) as compared to control (28 +/- 2 and 52 +/- 4 pg/ml, respectively). Larger dose of PA (10 mu g) increases the expression of IL2 (75 +/- 3 pg/ml), TNF alpha (1380 +/- 120 pg/ml), IL1 alpha (495 +/- 10 pg/ml) and IL1 beta (110 +/- 7 pg/ml) as compared to controls described above. We also observed that 1 mu g dose of PA decreases IL4, IL6 and IL10 secretion to 9 +/- 1, 10 +/- 1 and 10 +/- 2 pg/ml, respectively, whereas 10 mu g dose also decreased them to 11 +/- 1, 12 +/- 2 and 30 +/- 3 pg/ml, respectively as compared to the background controls, i.e. 50 +/- 5, 50 +/- 2 and 215 +/- 9 pg/ml respectively. The ratio of IFN gamma to IL4 increased and the peak value at 4 h, came to 13 +/- 1 and 9.6 +/- 0.5 with 1 mu g and 10 mu g PA, respectively, which is an established parameter indicating a Th1 type response. Flow cytometry analysis of CD4+/CD8+ cells, and c-myc protein expression by splenocytes indicate that 1 mu g dose of PA causes 2-fold increase of CD4+ cells with no change in CD8+ cells. and 10-fold increase in c-myc protein, whereas 10 mu g dose increases CD4+ cells 4-fold, CD8+ cells 3-fold and c-myc protein 100-fold. The cell cycle data shows an induction of apoptosis in thymocytes and splenocytes with the large dose (10 mu g), whereas the 1 mu g dose does not show any apoptosis. This report indicates that a Tn1 response is induced in mice, after PA inoculation at a dose of 1 mu g/animal. Thus, cytokine mediated therapeutic strategies should consider the fact that an induction of large concentration of some cytokines might become detrimental to the host. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:157 / 165
页数:9
相关论文
共 50 条
  • [1] A novel allergen from Staphylococcus aureus induces mixed Th1/Th2 response
    Reginald, K.
    Westritschnig, K.
    Linhart, B.
    Jahn-Schmid, B.
    Spitzauer, S.
    Balic, N.
    Werfel, T.
    Stoecklinger, A.
    Thalhamer, J.
    Greisenegger, E.
    Kopp, T.
    Valenta, R.
    ALLERGY, 2010, 65 : 205 - 205
  • [2] Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection
    Brown, Aisling F.
    Murphy, Alison G.
    Lalor, Stephen J.
    Leech, John M.
    O'Keeffe, Kate M.
    Mac Aogain, Micheal
    O'Halloran, Dara P.
    Lacey, Keenan A.
    Tavakol, Mehri
    Hearnden, Claire H.
    Fitzgerald-Hughes, Deirdre
    Humphreys, Hilary
    Fennell, Jerome P.
    van Wamel, Willem J.
    Foster, Timothy J.
    Geoghegan, Joan A.
    Lavelle, Ed C.
    Rogers, Thomas R.
    McLoughlin, Rachel M.
    PLOS PATHOGENS, 2015, 11 (11)
  • [3] Role and plasticity of Th1 and Th17 responses in immunity to Staphylococcus aureus
    Ferraro, Alessandra
    Buonocore, Sofia M.
    Auquier, Philippe
    Nicolas, Isabelle
    Wallemacq, Hugues
    Boutriau, Dominique
    van der Most, Robbert G.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (12) : 2980 - 2992
  • [4] A minimized Fc binding peptide from protein A induces immunocyte proliferation and evokes Th1-type response in mice
    Sinha, P
    Sengupta, J
    Ray, PK
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 258 (01) : 141 - 147
  • [5] Enhanced Th1 response to Staphylococcus aureas infection in human lactoferrin-transgenic mice
    Guillén, C
    McInnes, IB
    Vaughan, DM
    Kommajosyula, S
    Van Berkel, PHC
    Leung, BP
    Aguila, A
    Brock, JH
    JOURNAL OF IMMUNOLOGY, 2002, 168 (08): : 3950 - 3957
  • [6] Staphylococcus aureus Esx Factors Control Human Dendritic Cell Functions Conditioning Th1/Th17 Response
    Cruciani, Melania
    Etna, Marilena P.
    Camilli, Romina
    Giacomini, Elena
    Percario, Zulema A.
    Severa, Martina
    Sandini, Silvia
    Rizzo, Fabiana
    Brandi, Valentina
    Balsamo, Giuliana
    Polticelli, Fabio
    Affabris, Elisabetta
    Pantosti, Annalisa
    Bagnoli, Fabio
    Coccia, Eliana M.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2017, 7
  • [7] A Higher Dose of Staphylococcus aureus Enterotoxin B Led to More Th1 and Lower Th2/Th1 Ratio in Th Cells
    Yuan, Jin
    Xu, Xiaoqian
    Wang, Zhongliang
    Tong, Ping
    Meng, Xuanyi
    Wu, Yong
    Li, Xin
    Gao, Jinyan
    Chen, Hongbing
    TOXINS, 2023, 15 (06)
  • [8] A Modulatory Interleukin-10 Response to Staphylococcal Peptidoglycan Prevents Th1/Th17 Adaptive Immunity to Staphylococcus aureus
    Frodermann, Vanessa
    Chau, Thu A.
    Sayedyahossein, Samar
    Toth, Judit M.
    Heinrichs, David E.
    Madrenas, Joaquin
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (02): : 253 - 262
  • [9] Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice
    Taylor, Jennifer M.
    Ziman, Melanie E.
    Huff, Jennifer L.
    Moroski, Nathan M.
    Vajdy, Michael
    Solnick, Jay V.
    VACCINE, 2006, 24 (23) : 4987 - 4994
  • [10] Peptidoglycan From Staphylococcus aureus Induces TH2 Immune Response in Mice
    Matsui, K.
    Nishikawa, A.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2012, 22 (02) : 80 - 86